337797 <common-name>2-[[n-[2-hydroxy-5-sulfo-3-[(2,5,6-trichloropyrimidin-4-yl)amino]anilino]-c-phenylcarbonimidoyl]diazenyl]-5-sulfobenzoic acid</common-name> <description>2-[[n-[2-hydroxy-5-sulfo-3-[(2,5,6-trichloropyrimidin-4-yl)amino]anilino]-c-phenylcarbonimidoyl]diazenyl]-5-sulfobenzoic acid has the chemical formula C24H16Cl3N7O9S2. With an average molecular weight of 716.90 g/mol, 2-[[n-[2-hydroxy-5-sulfo-3-[(2,5,6-trichloropyrimidin-4-yl)amino]anilino]-c-phenylcarbonimidoyl]diazenyl]-5-sulfobenzoic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>154734684</pubchem-id> <chemical-formula>C24H16Cl3N7O9S2</chemical-formula> <weight>716.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T20:45:43Z</created-at> <updated-at type="dateTime">2026-08-30T20:45:43Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1=CC=C(C=C1)C(=NNC2=CC(=CC(=C2O)NC3=C(C(=NC(=N3)Cl)Cl)Cl)S(=O)(=O)O)N=NC4=C(C=C(C=C4)S(=O)(=O)O)C(=O)O</moldb-smiles> <moldb-formula>C24H16Cl3N7O9S2</moldb-formula> <moldb-inchi>InChI=1S/C24H16Cl3N7O9S2/c25-18-20(26)29-24(27)30-22(18)28-16-9-13(45(41,42)43)10-17(19(16)35)32-34-21(11-4-2-1-3-5-11)33-31-15-7-6-12(44(38,39)40)8-14(15)23(36)37/h1-10,32,35H,(H,36,37)(H,28,29,30)(H,38,39,40)(H,41,42,43)</moldb-inchi> <moldb-inchikey>CTWANGYDBHNUHF-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">714.951651</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333690</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[n-[2-hydroxy-5-sulfo-3-[(2,5,6-trichloropyrimidin-4-yl)amino]anilino]-c-phenylcarbonimidoyl]diazenyl]-5-sulfobenzoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0288226</sync-id> <structure-inchikey>CTWANGYDBHNUHF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>2000000000000400000000000002000000000000000000200004000000000000200000000001400010020000002004000000000000000080000000100000044000000000400000008000000020000020000000000008081004080000008000000000010000000000000000100000020000003000000000000008000010000000010000000000800000000800000080000000000100000080000000004000000000000000004020000000084000000000000000000000088000000000008020000000020000002000000000000004000010000000000020000200000010000000000000000001000040000000408400400000000000044100400000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAtAAAAMAAAAIABBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGACgAAAAD BAcAKAAAAAMDBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZA aAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQIAGgAAAADAQEHAGgAAAADAgEGQCgA AAADBAZAKAAAAAMEBkAoAAAAAwQHQCgAAAADAwZAKAAAAAMEB0AoAAAAAwMR ACAAAAABEQAgAAAAAREAIAAAAAEQACAAAAAGCAAoAAAAAwIIACgAAAADAggA YAAAAAEBBwAoAAAAAwMHACgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQGgAAAAD AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDARAAIAAAAAYIACgAAAADAggA KAAAAAMCCABgAAAAAQEGACgAAAADBAgAKAAAAAMCCABoAAAAAwEBCwABaAwB AmgMAgNoDAMEaAwEBWgMAwYgBgcoAgcIIAgJIAkKaAwKC2gMCwxoDAwNaAwN DmgMDg8gDRAgEBEgERJoDBITaAwTFGgMFBVoDBUWaAwVFwATGAASGQALGgAa GwgCGhwIAhodAAYeIB4fKAIfICAgIWgMISJoDCIjaAwjJGgMJCVoDCMmACYn CAImKAgCJikAISogKisoAiosIAUAaAwOCWgMFhFoDCUgaAxCBAAAAAYABQQD AgEGCgsMDQ4JBhITFBUWEQYhIiMkJSAXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:46Z</structure-indexed-at> </compound>